> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Post-market Surveillance Practices
- URL: https://www.fdaweb.com/comments-sought-on-post-market-surveillance-practices/
- Published: 2019-11-07T12:00:00.000Z
- Updated: 2026-09-14T15:52:23.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145444

*Federal Register* notice: FDA is seeking comments on a draft document that details best practices for drug safety surveillance entitled “Best Practices in Drug and Biological Product Postmarket Safety Surveillance for FDA Staff.” The document discusses risk-based principles that support ongoing FDA postmarketing safety surveillance for drug and biological products. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-11-07/pdf/2019-24332.pdf?ref=fdaweb.com).